BEUDAMED
    FDA Adverse Event Injury Summary report: N

    SYNVISC PFS 8MG/ML (3X2ML)

    MDR report key: 14267379 · Received May 2, 2022

    Report

    Report Number
    MW5109479
    Event Type
    Injury
    Date Received
    May 2, 2022
    Date of Event
    April 29, 2022
    Report Date
    April 29, 2022
    Manufacturer
    GENZYME CORPORATION
    Product Code
    MOZ
    UDI-DI
    58468009001
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    IN, US
    Reporter Occupation
    UNKNOWN
    Health Professional
    N

    Narratives

    Description of Event or Problem · 0

    THE PT REPORTED BEING DIAGNOSED WITH ATRIAL FIBRILLATION. PRESCRIBER: (B)(6).

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1218655 SYNVISC PFS 8MG/ML (3X2ML) ACID, HYALURONIC, INTRAARTICULAR MOZ GENZYME CORPORATION 58468009001

    Patients

    Seq Age Sex Outcome Treatment
    1 77 YR Female